Distribuzione geografica
Continente #
NA - Nord America 713
EU - Europa 491
AS - Asia 41
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.251
Nazione #
US - Stati Uniti d'America 693
IT - Italia 236
DE - Germania 108
NL - Olanda 98
CN - Cina 25
CA - Canada 20
CH - Svizzera 17
GB - Regno Unito 10
IN - India 8
UA - Ucraina 6
IE - Irlanda 5
EG - Egitto 4
FI - Finlandia 4
VN - Vietnam 4
SE - Svezia 3
FR - Francia 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
EU - Europa 1
LT - Lituania 1
SG - Singapore 1
Totale 1.251
Città #
Chandler 130
Naples 120
Amsterdam 98
Ashburn 83
Lawrence 33
Millbury 33
Krefeld 32
Des Moines 24
Boston 19
Basel 17
Napoli 17
Washington 15
Milan 10
Ottawa 10
Wilmington 10
Beijing 9
Pozzuoli 9
Rome 6
Bologna 4
Council Bluffs 4
Dong Ket 4
Nanjing 4
Fairfield 3
Jiaxing 3
Lappeenranta 3
Mariglianella 3
Richmond 3
Salerno 3
Shenyang 3
Cairo 2
Caserta 2
Changsha 2
Hanover 2
Houston 2
Paris 2
Princeton 2
Smithtown 2
Tokyo 2
Bari 1
Bayreuth 1
Boydton 1
Brussels 1
Cardito 1
Cava 1
Cava De' Tirreni 1
Desio 1
Dubai 1
Dublin 1
Ercolano 1
Fisciano 1
Foggia 1
Formia 1
Gragnano 1
Hebei 1
Helsinki 1
La Canada Flintridge 1
London 1
Los Angeles 1
Marano di Napoli 1
Melbourne 1
Monteforte Irpino 1
Montreal 1
Nanchang 1
Norwalk 1
Nuremberg 1
Perugia 1
Peterborough 1
Phoenix 1
Pontelandolfo 1
Redwood City 1
San Salvatore Telesino 1
Savoca 1
Singapore 1
Taramani 1
Tianjin 1
Torre Annunziata 1
Turin 1
Villafranca Tirrena 1
Vilnius 1
Zhengzhou 1
Totale 772
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 125
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? 43
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 40
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 38
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 36
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 35
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 32
Current evidence on the management of hepatitis B in pregnancy 31
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 31
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 30
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 29
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 29
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 28
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 28
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 27
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 27
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 26
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 25
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 25
Gastrointestinal tract diseases as a risk factor for SARSCoV2 rectal shedding? An Italian report on 10 COVID-19 patients 25
Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients 25
Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy 24
Further findings concerning endothelial damage in covid-19 patients 23
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension 22
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study 21
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 21
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection 20
A transient increase in the serum ancas in patients with sars-cov-2 infection: A signal of subclinical vasculitis or an epiphenomenon with no clinical manifestations? a pilot study 20
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 19
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 18
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 17
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 17
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 17
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 17
No Detection of SARS-CoV-2 RNA on Urethral Swab in Patients with Positive Nasopharyngeal Swab 17
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 16
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status 15
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 15
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 15
Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy? 15
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 14
Soluble urokinase receptor as a promising marker for early prediction of outcome in covid-19 hospitalized patients 14
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 13
Diabetes and COVID-19: The potential role of mTOR 13
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 13
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 13
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 12
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development 12
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 11
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 11
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 11
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 11
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 10
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 10
Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia 10
Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life 'LIver Network Activity' (LINA) cohort update results 10
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 9
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 9
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 9
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 9
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 8
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 8
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 7
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 6
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 6
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 5
Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy 5
Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge 4
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study 3
Update on the Management of Surgical Site Infections 3
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients 3
Present and future of siderophore-based therapeutic and diagnostic approaches in infectious diseases 2
Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy 2
Preventing sepsis development in complicated urinary tract infections 2
Totale 1.372
Categoria #
all - tutte 5.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.938

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 2 2 2 6 0 1 3
2019/202047 12 3 1 1 6 1 3 2 1 2 12 3
2020/202174 5 1 2 2 18 1 16 5 9 6 5 4
2021/2022230 11 2 3 1 1 5 8 19 10 27 60 83
2022/2023673 36 22 21 21 60 77 39 167 79 106 35 10
2023/2024326 24 79 107 48 48 20 0 0 0 0 0 0
Totale 1.372